| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 167,071 | 175,405 | 157,862 | 161,933 | | Cost of Revenue | 101,610 | 103,911 | 99,237 | 104,864 | | | Gross Profit | 65,461 | 71,494 | 58,625 | 57,069 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 50,430 | 55,698 | 45,289 | 42,016 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,709 | 5,659 | 3,306 | 3,757 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,322 | 10,137 | 10,030 | 11,296 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 65 | 194 | 166 | 566 | | Earnings Before Interest And Taxes | 9,387 | 10,331 | 10,196 | 11,862 | | Interest Expense | 1,471 | 1,501 | 735 | 1,050 | | Income Before Tax | 7,916 | 8,830 | 9,461 | 10,812 | | Income Tax Expense | 2,800 | 3,661 | 3,579 | 4,670 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,116 | 5,169 | 5,882 | 6,142 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,116 | 5,169 | 5,882 | 6,142 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,116 | $5,169 | $5,882 | $6,142 |
|
0.51% Nasdaq 
Income Statement
